News
1d
TipRanks on MSNSanofi’s Phase 3 Study on Frexalimab: A Potential Game-Changer for Multiple Sclerosis Treatment
The study tests two interventions: Frexalimab, an experimental drug administered via infusion, and Teriflunomide, an active comparator given as an oral tablet. Both are designed to manage relapsing ...
A new University of British Columbia study finds that MS patients visit doctors more frequently for mental health issues and fatigue many years before diagnosis.
MS Society Preston Group volunteers The MS Society Group in Preston is looking for a finance volunteer to help prevent the closure of the group. With a ...
A Nebraska woman has become the first patient in the world to undergo a groundbreaking new treatment for multiple sclerosis.
Columnist Ben Hofmeister is able to tell when people want the short answer to questions about his health. Too bad most MS answers are long.
2d
Health and Me on MSN7 Multiple Sclerosis Myths You Need to Stop Believing Right Now
Multiple sclerosis can affect the body long before obvious symptoms appear. Myths around MS, from mobility to pregnancy, ...
In a surprising discovery, scientists at Washington University School of Medicine in St. Louis have found that people with ...
Columnist Desiree Lama has had to find some self-care strategies for managing her MS while also staying atop her work as a ...
ST. PAUL – The annual fundraiser golf tournament held at the St. Paul Golf Course on Aug. 8 drew 200 golfers and raised ...
People with multiple sclerosis tend to have frequent doctor's appointments up to 15 years before diagnosis, recent research ...
A wheelchair user with multiple sclerosis (MS) who embarked on a coast-to-coast challenge is "devastated" to have paused the ...
In all, his trip would take him 24,901 miles and through about 80 pairs of shoes. For perspective, that's more than 6.8 miles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results